MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-OD-07-0029623
Oro Pharmaceuticals Private Limited
Oro Pharmaceuticals Private Limited - pharma in Cuttack, Odisha, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹1.29 Cr
▼ 7% YoY
Net profit · FY 2025
₹4.1 Lakh
Net margin 3.2%
EBITDA · FY 2025
₹19.81 Lakh
EBITDA margin 15.3%
Authorised capital
₹60 Lakh
Registered with MCA
Paid-up capital
₹60 Lakh
Issued & subscribed
Open charges
₹3.99 Cr
Secured borrowings
Company age
22 yrs
Est. 2004
Employees · EPFO
16
Provident fund records
About Oro Pharmaceuticals Private Limited
Data last updated:
Oro Pharmaceuticals Private Limited is a private limited company based in Cuttack, Odisha, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 09 March 2004 and has been in existence for over 22 years.
The company is registered with the Registrar of Companies (ROC), Cuttack, under CIN U24232OR2004PTC007517. Its GSTIN is 21AAACO6757D2ZP (Odisha). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹60 Lakh and a paid-up capital of ₹60 Lakh. It is led by directors including Akshaya Kumar Jena and Namita Jena.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Bahar Bisinabarlink Road, Cuttack, Odisha, India – 753012.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.29 Cr, a decline of 7% compared to the previous year. For the same year it recorded a net profit of ₹4.1 Lakh (net margin 3.2%) and EBITDA of ₹19.81 Lakh (EBITDA margin 15.3%). Revenue has declined at a compounded annual rate (CAGR) of 7% over three years and 1% over five years.
The company has about 16 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹3.99 Cr on record.
Oro Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-OD-07-0029623). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24232OR2004PTC007517
Registration Number 007517
Incorporation Date 09 March 2004
ROC Cuttack
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-OD-07-0029623
Recognitions & Rankings of Oro Pharmaceuticals
Contact details
Oro Pharmaceuticals Private Limited's registered office is in Cuttack, Odisha. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressBahar Bisinabarlink Road, Cuttack, Odisha, India – 753012
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Oro Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Oro Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Oro Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Oro Pharmaceuticals Private Limited, buy the company report.
Financials of Oro Pharmaceuticals Private Limited
FY 2024 filings availableOro Pharmaceuticals Private Limited reported revenue of ₹1.29 Cr (down 7% YoY) for FY 2025.
Revenue · FY 2025
₹1.29 Cr ▼ 7%
Net profit · FY 2025
₹4.1 Lakh margin 3.2%
EBITDA · FY 2025
₹19.81 Lakh margin 15.3%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 7%
3 years · compounded
▼ 7%
5 years · compounded
▼ 1%
EBITDA CAGR growth
1 year
▼ 23%
3 years · compounded
▼ 4%
5 years · compounded
▲ 6%
Revenue has declined at a compounded annual rate (CAGR) of 1% over five years, including a 7% fall in the latest year. EBITDA fell 23% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹19.81 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹4.1 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 15.3% | ||||
| Net Profit Margin | 3.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Oro Pharmaceuticals Private Limited, buy the company report.
Board of directors of Oro Pharmaceuticals Private Limited
Oro Pharmaceuticals has 3 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Akshaya Kumar Jena | Director | 19 Feb 2024 | 2 Years 8 Months | Current |
| Namita Jena | Director | 19 Feb 2024 | 2 Years 8 Months | Current |
| Saswat Anumeya Jena | Director | 19 Feb 2024 | 2 Years 8 Months | Current |
Peer comparison
Oro Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| M A Medifact Pharmaceuticals Private Limited | ₹1.3 Cr (FY 2016) | -11.0% | Delhi, India | |||
| Advanceconcept Pharmaceuticals Private Limited | ₹1.3 Cr (FY 2024) | -18.0% | Bareilly, Uttar Pradesh, India | |||
| Oro Pharmaceuticals Private Limitedthis company | ₹1.29 Cr (FY 2025) | ₹4.1 Lakh | 3.2% | -7.0% | Cuttack, Odisha, India | |
| Biomi Life Sciences Private Limited | ₹1.29 Cr (FY 2024) | -45.0% | Chandrapur, Maharashtra, India | |||
| Bayonet Pharmaceuticals Private Limited | ₹1.29 Cr (FY 2025) | 12.0% | Chennai, Tamil Nadu, India |
To see the full peer comparison of Oro Pharmaceuticals Private Limited, buy the company report.
Auditor
Oro Pharmaceuticals Private Limited is audited by PAWAN MANISHA & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| PAWAN MANISHA & ASSOCIATES | FY 2023 | 325736E |
Shareholding
The shareholding of Oro Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Oro Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹3.99 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 25 Feb 2022 | 100554663 | Bank of India | ₹23.37 Lakh | Open | |
| 27 Feb 2006 | 80023395 | Bank of India | ₹3.76 Cr | Open |
To see the full charge records of Oro Pharmaceuticals Private Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Oro Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Oro Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Oro Pharmaceuticals has 2 GST registrations: 1 active and 1 cancelled or inactive.
Total GSTINs
2
Active
1
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 21AAACO6757D2ZP | Odisha | Active | 16 May 2018 |
To see the full GST registrations and return filing status of Oro Pharmaceuticals Private Limited, buy the company report.
Recent activity
Oro Pharmaceuticals Private Limited has 7 board changes on record since 2024: 3 appointments and 4 cessations. The latest: Ramakanta Jena ceased to be Director on 07 Mar 2024.
Charges
A charge with Bank Of India of Rs. 375.55 Lakh registered on 27 Feb 2006 with Charge ID 80023395 was modified on 30 Dec 2024.
AGM
Oro Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Oro Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Cuttack.
Ceased
Ramakanta Jena ceased to be Director.
Appointed
Akshaya Kumar Jena was appointed as Director.
Ceased
Amiya Kumar Ray ceased to be Director.
Ceased
Bishnu Charan Jena ceased to be Director.
Appointed
Namita Jena was appointed as Director.
Appointed
Saswat Anumeya Jena was appointed as Director.
Ceased
Shanta Ray ceased to be Director.
Charges
A charge with Bank Of India amounted to Rs. 23.37 Lakh with Charge ID 100554663 was registered on 25 Feb 2022.
Charges
A charge with Bank Of India amounted to Rs. 375.55 Lakh with Charge ID 80023395 was registered on 27 Feb 2006.
1 earlier event is in the company report.
Frequently asked questions
Oro Pharmaceuticals is an active private limited company based in Cuttack, Odisha, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 09 March 2004 (22+ years old) and is registered under CIN U24232OR2004PTC007517.
Oro Pharmaceuticals has 3 current directors:
- Akshaya Kumar Jena - Director
- Namita Jena - Director
- Saswat Anumeya Jena - Director
The latest financial statements of Oro Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Oro Pharmaceuticals is 21AAACO6757D2ZP, registered in Odisha. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Oro Pharmaceuticals is U24232OR2004PTC007517. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Oro Pharmaceuticals was incorporated on 09 March 2004, making it 22+ years old. It is registered with the Registrar of Companies, Cuttack.
The peers of Oro Pharmaceuticals by revenue are M A Medifact Pharmaceuticals Private Limited, Advanceconcept Pharmaceuticals Private Limited, Biomi Life Sciences Private Limited, Bayonet Pharmaceuticals Private Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading).
Ramakanta Jena ceased to be Director on 07 Mar 2024. Akshaya Kumar Jena was appointed as Director on 19 Feb 2024. Amiya Kumar Ray ceased to be Director on 19 Feb 2024. Oro Pharmaceuticals has 7 board changes on record in total.
Yes, Oro Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-OD-07-0029623).
The registered office of Oro Pharmaceuticals is at Bahar Bisinabarlink Road, Cuttack, Odisha, India – 753012.
Oro Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.